Commerce Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.14M Sell
9,480
-1,053
-10% -$358K 0.02% 438
2025
Q4
$4.19M Buy
10,533
+6,002
+132% +$2.66M 0.02% 343
2025
Q3
$2.07M Sell
4,531
-5
-0.1% -$2.04K 0.01% 495
2025
Q2
$1.48M Sell
4,536
-21
-0.5% -$5.81K 0.01% 550
2025
Q1
$1.23M Buy
4,557
+55
+1% +$14.1K 0.01% 576
2024
Q4
$1.06M Sell
4,502
-20
-0.4% -$5.26K 0.01% 618
2024
Q3
$1.24M Sell
4,522
-95
-2% -$24.7K 0.01% 588
2024
Q2
$1.12M Sell
4,617
-39
-0.8% -$6.16K 0.01% 597
2024
Q1
$696K Sell
4,656
-27
-0.6% -$4.5K ﹤0.01% 739
2023
Q4
$896K Buy
4,683
+77
+2% +$13.1K 0.01% 641
2023
Q3
$816K Buy
4,606
+28
+0.6% +$5.34K 0.01% 628
2023
Q2
$870K Sell
4,578
-30
-0.7% -$5.95K 0.01% 612
2023
Q1
$923K Buy
4,608
+158
+4% +$33.2K 0.01% 582
2022
Q4
$1.06M Sell
4,450
-27
-0.6% -$5.76K 0.01% 547
2022
Q3
$896K Sell
4,477
-20,170
-82% -$3.85M 0.01% 572
2022
Q2
$3.6M Buy
24,647
+20,289
+466% +$2.88M 0.03% 335
2022
Q1
$712K Buy
4,358
+100
+2% +$15.2K ﹤0.01% 689
2021
Q4
$722K Buy
4,258
+21
+0.5% +$3.9K ﹤0.01% 722
2021
Q3
$800K Sell
4,237
-1,604
-27% -$301K 0.01% 678
2021
Q2
$990K Buy
5,841
+53
+0.9% +$7.76K 0.01% 614
2021
Q1
$817K Sell
5,788
-33,798
-85% -$5.09M 0.01% 653
2020
Q4
$5.14M Buy
39,586
+5,051
+15% +$674K 0.04% 298
2020
Q3
$5.03M Buy
34,535
+3,267
+10% +$464K 0.05% 264
2020
Q2
$4.63M Buy
31,268
+26,788
+598% +$3.61M 0.05% 265
2020
Q1
$488K Buy
4,480
+1,390
+45% +$160K 0.01% 594
2019
Q4
$356K Buy
+3,090
New +$308K ﹤0.01% 768

Other funds holding ALNY